PATENT CLAIM ANALYSIS

Application Number: 16256987
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-08
Patent Classification: ["514", "260100"]

Abstract:
Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.

Claim (Index 49):
The method of  claim 48 , further comprising co-administering an anti-inflammatory agent to the subject.

Metadata:
- Claim Count in Document: 152.0
- Percentile: 99.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15662861', '15700040', '16195506', '15757238', '16016290']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8496463852239606
- 35 USC 102 Novelty (BERT): 0.582720522396297
- Combined Prediction Score: 0.8229537989411944
- Mean Citation Score: 563.0521120000002
- Max Citation Score: 632.4801
- Similarity Product: 387.19498168208605

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test